BLOOD SCREENING MARKET ANALYSIS

Regional Analysis

Blood Screening Market- Regional Analysis

On the basis of region, the global blood screening market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America is expected to dominate the blood screening market, owing to acquisitions by major players in the region. For Instance, in July 2017, Grifols acquired the NAT (Nucleic Acid Testing) donor screening unit from the U.S. Company Hologic for a purchase price of US$ 1,850 Million. This agreement bound to research, development, and manufacture of assays and instruments activities by using NAT technology that allows detection of infectious agents present in blood and plasma donations, contributing to greater transfusion safety.

Asia Pacific is expected to witness significant growth in the blood screening market due to increasing government initiatives and rising awareness regarding transmission of diseases during blood transfusion. For instance, in June 2015, a National Blood Donor Vigilance Programme (NBDVP) was launched in India on the World Blood Donor Day. The objectives of the NBDVP is to increase blood donation frequency and reduce the frequency of adverse event and to analyze the risk factor and evaluate preventive measure.